Form 4 Filing for BioCardia, Inc. - Insider Transaction

This filing details a transaction by Edward M. Gillis, Senior Vice President of Devices at BioCardia, Inc. On July 2, 2026, Gillis disposed of 17,269 shares of Common Stock, acquired at a price of $1.24 per share. These shares were withheld by the issuer to satisfy tax obligations related to vested RSUs. Following this transaction, Gillis owns 54,126 shares directly. Additionally, on July 6, 2026, Gillis was granted a stock option to purchase 29,442 shares of Common Stock at an exercise price of $1.20 per share. This option vests monthly starting August 6, 2026, with 61,139 shares owned after the option grant.